Franklin Resources Inc Eli Lilly & CO Transaction History

Franklin Resources Inc

$304 Billion
Q1 2024

A detailed history of Franklin Resources Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Franklin Resources Inc holds 3,876,900 shares of LLY stock, worth $3.18 Billion. This represents 0.99% of its overall portfolio holdings.

Number of Shares

3,876,900

Previous 2,322,197 66.95%

Holding current value

$3.18 Billion

Previous $1.35 Billion 122.81%

% of portfolio

0.99%

Previous 0.66%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $921 Million - $1.23 Billion	1,554,703 Added 66.95%	3,876,900 $3.02 Billion
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $44.6 Million - $52.6 Million	-84,980 Reduced 3.53%	2,322,197 $1.35 Billion
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $340 Million - $468 Million	-781,055 Reduced 24.5%	2,407,177 $1.29 Billion
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $99.7 Million - $133 Million	-284,330 Reduced 8.19%	3,188,232 $1.5 Billion
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $187 Million - $219 Million	601,267 Added 20.94%	3,472,562 $1.19 Billion

Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $139 Million - $161 Million	430,847 Added 17.65%	2,871,295 $1.05 Billion
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $45.4 Million - $51.7 Million	-153,156 Reduced 5.91%	2,440,448 $789 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $108 Million - $127 Million	-387,615 Reduced 13.0%	2,593,604 $841 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $46.4 Million - $57.6 Million	197,610 Added 7.1%	2,981,219 $854 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $254 Million - $315 Million	-1,129,787 Reduced 28.87%	2,783,609 $769 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $187 Million - $230 Million	-842,415 Reduced 17.71%	3,913,396 $904 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $22.9 Million - $29.6 Million	126,792 Added 2.74%	4,755,811 $1.09 Billion
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $234 Million - $303 Million	-1,424,951 Reduced 23.54%	4,629,019 $865 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $152 Million - $201 Million	1,162,920 Added 23.78%	6,053,970 $1.02 Billion
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $16.7 Million - $19.4 Million	-114,463 Reduced 2.29%	4,891,050 $724 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $138 Million - $166 Million	-1,011,270 Reduced 16.81%	5,005,513 $825 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $186 Million - $230 Million	-1,562,622 Reduced 20.62%	6,016,783 $835 Million
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $65 Million - $80.5 Million	607,932 Added 8.72%	7,579,405 $996 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $81.4 Million - $88.5 Million	762,291 Added 12.28%	6,971,473 $780 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $223 Million - $261 Million	-2,015,541 Reduced 24.51%	6,209,182 $688 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $547 Million - $644 Million	-4,911,738 Reduced 37.39%	8,224,723 $1.07 Billion
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $1.11 Billion - $1.25 Billion	-10,502,127 Reduced 44.43%	13,136,461 $1.52 Billion
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $503 Million - $629 Million	-5,863,794 Reduced 19.88%	23,638,588 $2.54 Billion
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $230 Million - $264 Million	-3,039,393 Reduced 9.34%	29,502,382 $2.52 Billion
Q1 2018 May 10, 2018	BUY	$74.21 - $87.6 $298 Million - $352 Million	4,022,251 Added 14.1%	32,541,775 $2.52 Billion
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $61.8 Million - $66.3 Million	754,681 Added 2.72%	28,519,524 $2.41 Billion
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $2.14 Billion - $2.38 Billion	27,764,843	27,764,843 $2.37 Billion

Others Institutions Holding LLY

# of Institutions

3,712

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $779B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Eli Lilly & CO Transaction History